BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 18005928)

  • 1. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole.
    Swidsinski A; Mendling W; Loening-Baucke V; Swidsinski S; Dörffel Y; Scholze J; Lochs H; Verstraelen H
    Am J Obstet Gynecol; 2008 Jan; 198(1):97.e1-6. PubMed ID: 18005928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
    Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
    J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial.
    McDonald HM; O'Loughlin JA; Vigneswaran R; Jolley PT; McDonald PJ
    Obstet Gynecol; 1994 Sep; 84(3):343-8. PubMed ID: 8058228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.
    Swidsinski A; Dörffel Y; Loening-Baucke V; Schilling J; Mendling W
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):41-6. PubMed ID: 20955467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis.
    Hillier SL; Lipinski C; Briselden AM; Eschenbach DA
    Obstet Gynecol; 1993 Jun; 81(6):963-7. PubMed ID: 8497364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy.
    Hanson JM; McGregor JA; Hillier SL; Eschenbach DA; Kreutner AK; Galask RP; Martens M
    J Reprod Med; 2000 Nov; 45(11):889-96. PubMed ID: 11127100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of arilin (Dr.Wolff) in the treatment of bacterial vaginosis and trichomoniasis during the period of 01.10.2003-31.12.2003].
    Staĭkova N
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():34-5. PubMed ID: 15323317
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.
    Sanchez S; Garcia PJ; Thomas KK; Catlin M; Holmes KK
    Am J Obstet Gynecol; 2004 Dec; 191(6):1898-906. PubMed ID: 15592270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The bacterial vaginosis--treatment problems].
    Romanik MK; Ekiel AM; Tomana L; Martirosian G
    Wiad Lek; 2007; 60(1-2):64-7. PubMed ID: 17607971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral metronidazole vs. Metrogel Vaginal for treating bacterial vaginosis. Cost-effectiveness evaluation.
    Ransom SB; McComish JF; Greenberg R; Tolford DA
    J Reprod Med; 1999 Apr; 44(4):359-62. PubMed ID: 10319306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment failure of bacterial vaginosis is not associated with higher loads of Atopobium vaginae and Gardnerella vaginalis.
    Ferreira CST; Donders GG; Parada CMGL; Tristão ADR; Fernandes T; da Silva MG; Marconi C
    J Med Microbiol; 2017 Aug; 66(8):1217-1224. PubMed ID: 28792372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherent biofilms in bacterial vaginosis.
    Swidsinski A; Mendling W; Loening-Baucke V; Ladhoff A; Swidsinski S; Hale LP; Lochs H
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1013-23. PubMed ID: 16260520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems.
    Aroutcheva AA; Simoes JA; Behbakht K; Faro S
    Clin Infect Dis; 2001 Oct; 33(7):1022-7. PubMed ID: 11528575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis.
    Reichman O; Akins R; Sobel JD
    Sex Transm Dis; 2009 Nov; 36(11):732-4. PubMed ID: 19704395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the Bacterial Vaginosis-Associated Biofilm: A Multiplex Gardnerella vaginalis and Atopobium vaginae Fluorescence In Situ Hybridization Assay Using Peptide Nucleic Acid Probes.
    Hardy L; Jespers V; Dahchour N; Mwambarangwe L; Musengamana V; Vaneechoutte M; Crucitti T
    PLoS One; 2015; 10(8):e0136658. PubMed ID: 26305575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissimilarity in the occurrence of Bifidobacteriaceae in vaginal and perianal microbiota in women with bacterial vaginosis.
    Swidsinski A; Dörffel Y; Loening-Baucke V; Mendling W; Schilling J; Patterson JL; Verstraelen H
    Anaerobe; 2010 Oct; 16(5):478-82. PubMed ID: 20620215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment.
    Verstraelen H; Swidsinski A
    Curr Opin Infect Dis; 2013 Feb; 26(1):86-9. PubMed ID: 23221767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.
    Sobel JD; Ferris D; Schwebke J; Nyirjesy P; Wiesenfeld HC; Peipert J; Soper D; Ohmit SE; Hillier SL
    Am J Obstet Gynecol; 2006 May; 194(5):1283-9. PubMed ID: 16647911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
    Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
    Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.